Next Article in Journal
Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells
Next Article in Special Issue
Boron Hydrogen Compounds: Hydrogen Storage and Battery Applications
Previous Article in Journal
In Vitro and In Silico Interaction Studies with Red Wine Polyphenols against Different Proteins from Human Serum
Previous Article in Special Issue
The Reaction of Hydrogen Halides with Tetrahydroborate Anion and Hexahydro-closo-hexaborate Dianion
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 21
10.3390/molecules26216687
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Zwitter-Ionic Conjugate of Nido-Carborane with Cholesterol

by
Anna A. Druzina
1,*,
Olga B. Zhidkova
1,
Nadezhda V. Dudarova
1,
Natalia A. Nekrasova
1,2,
Kyrill Yu. Suponitsky
1,3,
Sergey V. Timofeev
1 and
Vladimir I. Bregadze
1
1
A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119991 Moscow, Russia
2
M.V. Lomonosov Institute of Fine Chemical Technology, MIREA—Russian Technological University, 86 Vernadsky Av., 119571 Moscow, Russia
3
Basic Department of Chemistry of Innovative Materials and Technologies, G.V. Plekhanov Russian University of Economics, 36 Stremyannyi Line, 117997 Moscow, Russia
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(21), 6687; https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26216687
Submission received: 5 October 2021 / Revised: 30 October 2021 / Accepted: 4 November 2021 / Published: 5 November 2021
(This article belongs to the Special Issue Transition Metal and Main Group Hydrides: Structure, Reactivity, and Applications)
Browse Figures
Versions Notes

Abstract

:
9-HC≡CCH2Me2N-nido-7,8-C2B9H11, a previously described carboranyl terminal alkyne, was used for the copper(I)-catalyzed azide-alkyne cycloaddition with azido-3β-cholesterol to form a novel zwitter-ionic conjugate of nido-carborane with cholesterol, bearing a 1,2,3-triazol fragment. The conjugate of nido-carborane with cholesterol, containing a charge-compensated group in the linker, can be used as a precursor for the preparation of liposomes for BNCT (Boron Neutron Capture Therapy). The solid-state molecular structure of a nido-carborane derivative with the 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 terminal dimethylamino group was determined by single-crystal X-ray diffraction.

Graphical Abstract

1. Introduction

Due to their unique structure and chemical properties, as well their wide range of applications, polyhedral boron hydrides attract the continued interest of researchers working in various fields [1,2,3]. Nido-Carborane or 7,8-dicarba-nido-undecaborate anion and its derivatives have highly polarizable spherical aromaticity as a result of their σ-delocalized electron density [4,5]. Therefore, they display characteristic electronic properties [6], and thermal [7], chemical and photochemical stability [8]. All these features make them interesting systems for use in such fields as materials science [9,10] and medicinal chemistry [11,12,13,14]. Boron neutron capture therapy (BNCT) for cancer is one of the most significant applications of nido-carborane derivatives in medicine [15].
The basic concept of BNCT for cancer, proposed for the first time by Gordon L. Locher in 1936, is based on the selective accumulation of the non-radioactive isotope 10B in tumor cells, and their subsequent treatment with a flux of thermal neutrons [16]. On absorption of a thermal neutron by a 10B atom, an excited 11B atom is formed, which almost immediately undergoes a fission reaction, producing two high-energy heavy ions (4He2+ and 7Li3+) that selectively destroy tumor cells, while not causing serious damage to the surrounding normal cells [17]. To ensure the successful development of BNCT, the selective delivery and high accumulation of boron in the tumor tissue, at a therapeutic concentration (20–35 µg 10B/g), are required for subsequent irradiation with thermal neutrons [17]. For this purpose, the development of efficient 10B delivery carriers to tumors is important in BNCT.
The promising trend towards the achievement of the necessary therapeutic concentrations of boron in the tumor is enabled by the use of nido-carborane derivatives containing high contents of boron atoms in their molecules [15,18,19]. Another promising trend is the development of various nanomaterials, such as liposomes, that could be used as both boron host molecules and for the targeted delivery of boron to cancer cells [20,21].
Liposomes are artificially constructed spherical vesicles consisting of a phospholipid bilayer [22]. First discovered in 1961 by Alec Bangham, liposomes are now being studied for their ability to overcome cell membranes and transport boron clusters into a cancerous tumor. There are examples of the production of liposomes based on polyhedral boron hydrides containing borane and carborane derivatives both in the aqueous core and in the composition of the lipid bilayer [23,24,25]. The main difference between tumor and normal cells is the presence of a phospholipid/cholesterol shell with a diameter of approximately 15–20 nm, which is filled with cholesterol and glyceryl esters of long-chain alkyl carboxylic acids. This difference is based on an increase in the cholesterol requirement of tumor cells to promote the formation of new membranes. Therefore, the design of stable biocompatible boron-containing cholesterol nanostructures for the further creation of liposomal agents that contain derivatives of polyhedral boron hydrides is an effective approach that can solve the problem of the selective delivery of boron into tumor cells required to carry out BNCT. It was also recently shown that the inclusion of lipophilic boron-containing species in the bilayer of liposomes provides an attractive means of increasing the total boron content in liposomes contained within the formulation [26,27]. In addition, it was found that the encapsulation of nido-carborane with PEGylated liposome via the hydration of thin lipid films significantly suppresses tumors in BNCT [28].
It should be noted that the penetration of boronated liposomes through biological membranes, and their accumulation and retention in cells, largely depend on their charge. It is known that positively charged liposomes have better penetration through biological membranes than negatively charged ones. Positively charged liposomes containing carborane derivatives were found to be the most efficient delivery system for rat colon carcinoma and murine melanoma cell lines, as compared with negatively charged liposomes [29,30,31]. The high accumulation of such liposomes was probably due to favorable electrostatic interactions with the negatively charged outer leaflets of mammalian plasma membranes. This inspired us to synthesize positively charged nido-carborane derivatives with cholesterol for further use in the form of liposomes. The design of such compounds is based on the introduction of two ammonium centers, the first of which compensates for the negative charge of the nido-carborane cluster, and the second one provides the overall positive charge of the molecule.
There are only a few examples of lipids with polyhedral boron hydrides that contain molecules with zwitter-ionic characteristics [32,33]. Here, we use the “click” methodology to approach the synthesis of a novel zwitter-ionic nido-carboranyl-cholesterol conjugate. The hydrophilic part of such lipids contains a nido-carborane cluster, while the lipophilic part contains cholesterol. The resulting conjugate can be used to produce boron-containing liposomes as potential drugs for BNCT.

2. Results and Discussion

2.1. Synthesis of Nido-Carboranyl Cholesterol Bearing a 1,2,3-Triazole Fragment

The synthesis of biologically active molecules is a very important area of bioorganic chemistry. Among the methods for obtaining bioconjugates, the Cu(I)-catalyzed 1,3-dipolar [3+2] cycloaddition reaction of alkynes to azides is widely used, leading to the formation of 1,2,3 triazoles; this is known as the “click”-reaction” [34,35,36]. Earlier, the “click”-reaction was successfully used to obtain a wide range of conjugates of polyhedral boron hydrides with various biologically active molecules, such as nucleosides [37] and chlorine e6 [38], as well as derivatives of cholesterol based on cobalt/iron bis(dicarbollide) [26,27,33,39], closo-dodecaborate dianion [40] and nido-carborane [41]. In this work, we used cholesterol derivatives, as well as 3β-(2-azido-ethoxy)cholest-5-ene and nido-carboranyl derivatives, that contained different spacers between the boron cage and the terminal acetylene group.
Thus, to obtain a target positively charged conjugate by means of the “click” reaction, a previously described terminal alkyne based on nido-carborane derivative, with two ammonium centers in its spacer [9-HC≡CCH2Me2N(CH2)2Me2N-nido-7,8-C2B9H11]Br (1) [42], was used. However, it was found that the reaction of acetylene 1 with azido-3β-cholesterol 2 in the refluxing of ethanol in the presence of diisopropylethylamine (DIPEA) and a catalytic amount of CuI did not lead to the desired conjugate 3. During this reaction, we observed the elimination of the propargyl fragment of compound 1 and the formation of the nido-carborane derivative with the terminal dimethylamino group 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 (4). This can be explained by the acetylene-allen rearrangement under the action of DIPEA. The structure of compound 4 was confirmed by 1H, 11B and 13C NMR spectra. The spectral characteristics of 4 are in good agreement with the data given in the literature [42]. The structure of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4 was additionally confirmed via single-crystal X-ray diffraction study (Figure 1).
Further, we decided to use a more stable terminal nido-carboranyl alkyne with one ammonium center, 9-HC≡CCH2Me2N-nido-7,8-C2B9H11 (5) [42]. The usage of this alkyne excluded the elimination of the propargyl fragment in compound 5. Indeed, the reaction of acetylene 5 with azido-3β-cholesterol 2, under the same conditions as for compound 1, produced the novel conjugate of nido-carboranyl cholesterol 6 with a zwitter-ionic character of its target molecule (Scheme 1).
The structure of the obtained conjugate 6 was confirmed by 1H, 11B, 13C NMR, IR and high-resolution mass-spectrometry. The 1H and 13C NMR spectra of compound 6, along with the signals for the heteroaliphatic chain, contained signals that were characteristic of the triazole ring. In the 1H NMR spectrum, the signals for the protons of the CH group of triazole appeared at 8.37 ppm for conjugate 6. For 1,2,3-triazole 6, the 13C NMR spectrum showed signals for two carbon atoms of the triazole fragment at 140.6 ppm (the “nodal” atom) and at 123.3 ppm. In the 1H NMR spectrum, the signal of the methylene group next to the triazole cycle was observed at 4.63 ppm and the characteristic signals of the Me2N hydrogens appeared at 3.02 and 3.08 ppm. The characteristic signal for the proton at the double bond of the steroid core (CHst) of the conjugate was observed in the region of 5.33 ppm. The 11B NMR spectrum of 6 contained a pattern of eight signals (one singlet at 5.8 ppm and seven doublets at −5.7, −17.4, −19.4, −24.7, −26.9, −38.2 and −38.8 ppm), which demonstrates the absence of a plane of symmetry and unambiguously confirms the nido form. In the 1H-NMR spectra, the signal of the extra-hydrogen, as expected, was observed at approx. −3.2 ppm. In addition, the signals of the CHcarb groups in the 1H NMR spectra of 6 appeared as broad singlets at 2.81 and 2.06 ppm; in the 13C NMR spectra, the signals of CHcarb groups appeared at 33.6 and 39.7 ppm. The IR spectrum of compound 5 exhibited absorption band characteristic of the BH group at 2549 cm−1 and of the triazole ring at 1421 cm−1.
Based on synthesized zwitter-ionic compound, the preparation of the boronated liposomes was planned in order to deliver boron clusters into a cancer cell for the BNCT experiment.

2.2. Single-Crystal X-ray Diffraction Studies

The molecular and crystal structure of charge-compensating nido-carborane derivative with terminal dimethylamino group 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 (4) was determined by means of a single-crystal X-ray diffraction study (Figure 1). Crystals of 4 that were suitable for single-crystal X-ray analysis were obtained from the CDCl3 solution in the NMR tube.
The side substituent was relatively flexible and had the potential to form shortened C-H…H-B contacts with carborane cages, which would have influenced its orientation relative to the cage. On the other hand, relative orientation could have been affected by the crystal packing. Torsion angles and shortened H…H contacts, which defined the relative orientation, are provided in Table 1. In Table 1, we also included two recently studied compounds (Figure 2) [42], with similar substituents, at the same position in the carborane cage, as well as the calculated molecular geometry results obtained in an isolated state for all three compounds. Calculations were carried out in terms of density functional theory using the PBE0 function, which is widely used for the geometric optimization of a variety of classes of compounds [43,44,45,46].
Crystal packing analysis of the recently studied 9-NC≡CCH2Me2N-nido-7,8-C2B9H11 and 9-PhCH2Me2N-nido-7,8-C2B9H11 [42] revealed that the crystal packing of 9-PhCH2Me2N-nido-7,8-C2B9H11 is mostly stabilized by numerous weak van-der-Waals intermolecular interactions, while, in 9-NC≡CCH2Me2N-nido-7,8-C2B9H11, relatively strong π…π interactions between cyano groups were observed. In the case of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4, we found that the side substituent formed one slightly shortened C-H…H-B contact (2.31Å) while all the other intermolecular interactions were of the van-der-Waals type. Those observations agree well with the results shown in Table 1.
It can be seen that, in all three compounds, the crystal packing influenced the molecular structure. This influence was relatively small (at least, all shortened H…H contacts were preserved upon the transferring of a molecule from an isolated state to a crystal) and appeared to be more pronounced for 9-NC≡CCH2Me2N-nido-7,8-C2B9H11, for which π…π intermolecular interactions were observed.

3. Materials and Methods

3.1. General Methods

[9-HC≡CCH2Me2N(CH2)2Me2N-nido-7,8-C2B9H11]Br 1 [42], azido-3β-cholesterol 2 [39,47] and 9-HC≡CCH2Me2N-nido-7,8-C2B9H11 5 [42] were prepared according to the literature. Cholesterol (Fisher Scientific, Loughborough, UK), diisopropylethylamine (Carl Roth GmbH, Karlsruhe, Germany) and CuI (PANREAC QUIMICA SA, Barcelona, Spain) were used without further purification. Ethanol, CH3CN and CH2Cl2 were commercial reagents of analytical grade. The reaction progress was monitored by thin-layer chromatography (Merck F245 silica gel on aluminum plates) and visualized using 0.1% PdCl2 in 3 M HCl. Acros Organics silica gel (0.060–0.200 mm) was used for column chromatography. The NMR spectra at 400.1 MHz (1H), 128.4 MHz (11B) and 100.0 MHz (13C) were recorded with a Bruker Avance-400 spectrometer (Bruker, Karlsruhe-Zurich, Switzerland-Germany). The residual signal of the NMR solvent relative to Me4Si was taken as the internal reference for the 1H- and 13C-NMR spectra. 11B-NMR spectra were referenced using BF3*Et2O as external standard. Infrared spectra were recorded on an IR Prestige-21 (SHIMADZU) instrument. High resolution mass spectra (HRMS) were measured on a micrOTOF II (Bruker Daltonic, Bremen, Germany) instrument using electrospray ionization (ESI). The measurements were conducted in a positive ion mode (interface capillary voltage −4500 V), with a mass range from m/z 50 to m/z 3000; external or internal calibration was performed with the ESI Tuning Mix, produced by Agilent. A syringe injection was used for the addition of the solutions to acetonitrile (flow rate 3 µL/min). Nitrogen was applied as a dry gas; the interface temperature was set at 180 °C.
The X-ray experiment for 4 was carried out using the SMART APEX2 CCD diffractometer (λ(Mo-Kα) = 0.71073 Å, graphite monochromator, ω-scans) at 120K. The collected data were processed using the SAINT and SADABS programs that were incorporated into the APEX2 program package [48]. The structure was solved using direct methods and was refined by the full-matrix least-squares procedure against F2 via an anisotropic approximation. The refinement was carried out with the SHELXTL program [49]. The CCDC number 2113014 contains the supplementary crystallographic data (Supplementary Materials) for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif (accessed on 14 July 2021).

3.2. General Procedure for the Synthesis of the Compounds 4 and 6

A mixture of azido-3β-cholesterol 2, alkyne, diisopropylethylamine and CuI in ethanol was heated under reflux for 3 h. Then, the reaction mixture was cooled to room temperature and was passed through ca. 2–3 cm of silica on a Schott filter. Then, the solvent was removed in vacuo. The crude product was purified on a silica column using CH2Cl2-CH3CN as an eluent to provide the desired products 4 or 6.

3.3. Synthesis of 9-Me2N(CH2)2Me2N-Nido-7,8-C2B9H11 (4)

9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 was prepared from azido-3β-cholesterol 2 (0.21 g, 0.45 mmol), boronated alkyne 1 (0.20 g, 0.45 mmol), diisopropylethylamine (1 mL, 0.74 g, 5.73 mmol) and CuI (0.009 g, 0.05 mmol) in 15 mL of ethanol. The product was purified on a silica column using CH2Cl2-CH3CN (1:1) as an eluent to give the white solid of 4 (0.07 g, yield 63%). The NMR data of 4 are in good agreement with the data in the literature [39]. Crystallographic data: crystals of 4. C8H27B9N2 are monoclinic, space group C2c: a = 32.1867(12)Å, b = 6.6299(3)Å, c = 16.1995(6)Å, β = 116.1480(10)°, V = 3103.1(2) Å3, Z = 8, M = 248.60, dcryst = 1.064 g⋅cm−3. wR2 = 0.1369 calculated on F2hkl for all 4947 independent reflections with 2θ < 62.0°, (GOF = 1.117, R = 0.0546 calculated on Fhkl for 3942 reflections with I > 2σ(I)).

3.4. Synthesis of 9-3β-Chol-O(CH2)2N3-CH-C-(CH2)Me2N-Nido-7,8-C2B9H11 (6)

9-3β-Chol-O(CH2)2N3-CH-C-(CH2)Me2N-nido-7,8-C2B9H11 was prepared from azido-3β-cholesterol 2 (0.09 g, 0.21 mmol), boronated alkyne 5 (0.06 g, 0.21 mmol), diisopropylethylamine (0.5 mL, 0.40 g, 2.87 mmol) and CuI (0.004 g, 0.02 mmol) in 7 mL of ethanol. The product was purified on a silica column using CH2Cl2-CH3CN (7:1) as an eluent to give the white solid of 6 (0.10 g, yield 72%). 1H NMR (400 MHz, acetone-d6) δ 8.37 (1H, s, CCHN3), 5.34 (1H, m, Cst(6)H), 4.69 (4H, s, -OCH2-CH2N3), 3.96 (2H, s, CH2NMe2), 3.17 (1H, m, Cst(3)H), 3.08 (3H, s, NMe2), 3.02 (3H, s, NMe2), 2.81 (1H, br. s, CHcarb), 2.31 (1H, m, Cst(H)), 2.40 (1H, m, Cst(H)), 2.06 (1H, br. s, CHcarb), 1.86 (6H, m, Cst(H),), 1.57–1.03 (22H, m, Cst(H)), 1.00 (3H, s, Cst(19)H3), 0.96 (3H, d, J = 6.3 Hz, Cst(21)H3,), 0.89 (3H, s, Cst(26)H3), 0.88 (3H, s, Cst(27)H3), 0.73 (3H, s, Cst(18)H3), −3.16 (1H, br. s., Hextra) ppm; 11B (128 MHz, acetone-d6) δ 5.8 (1B, s), −5.7 (1B, d, J = 148), −17.4 (2B, unsolved d), −19.4 (1B, unsolved d), −24.7 (1B, d, J = 142), −26.9 (1B, d, J = 147), −32.2 (1B, d, J = 116), −38.8 (1B, d, J = 144) ppm; 13C NMR (101 MHz, acetone-d6) δ 140.5 (CCHN3), 137.3 (Cst(5)), 123.3 (CCHN3), 121.5 (Cst(6)), 79.1 (Cst(3)), 66.0 (CCHN3-CH2), 61.2 (O-CH2), 56.7 (Cst(14)), 56.1 (Cst(17)), 51.9 (NMe2), 50.9 (NMe2), 50.7 (Cst(9)), 50.3 (CH2NMe2), 42.2 (Cst(4)), 39.7 (Ccarb), 39.4 (Cst(12)), 38.9 (Cst(13)), 37.0 (Cst(24)), 36.6 (Cst(1)), 36.1 (Cst(10)), 35.7 (Cst(22)), 33.6 (Ccarb), 31.8 (Cst(20)), 31.7 (Cst(8)), 28.2 (Cst(2)), 28.0 (Cst(7)), 27.8 (Cst(16)), 24.0 (Cst(25)), 23.6 (Cst(15)), 22.2 (Cst(23)), 22.0 (Cst(26), Cst(27)), 20.9 (Cst(11)), 18.8 (Cst(19)), 18.2 (Cst(21)), 11.3 (Cst(18)) ppm. IR (solid): ν = 2549 cm−1 (BH), 1421 cm−1 (triazole), HRMS-ESI+m/z for [C34H64B9N4O + H]+ calcd 642.6016, found: 642.6028.

4. Conclusions

In this work, the “click” reaction of 9-HC≡CCH2Me2N-nido-7,8-C2B9H11 with azido-3β-cholesterol, in a good yield, was conducted to prepare a novel zwitter-ionic conjugate of nido-carborane with cholesterol. We also studied the behavior of the nido-carborane derivative [9-HC≡CCH2Me2N(CH2)2Me2N-nido-7,8-C2B9H11]Br in the copper(I)-catalyzed azide-alkyne cycloaddition reaction with azido-3β-cholesterol, and revealed that during this process, in the presence of a strong base, acetylene-allen rearrangement occurred, resulting in the elimination of the propargyl fragment in carbonyl acetylene and the formation of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11. The solid-state molecular structure of this previously described compound was determined by means of single-crystal X-ray diffraction studies. Comparing the structure of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 with the previously described analogs shows that the flexibility of side substituent does not significantly affect the crystal packing. Based on synthesized zwitter-ionic conjugate, the preparation of the boronated liposomes was planned in order to deliver boron clusters into a cancer cell for BNCT experiments.

Supplementary Materials

The following are available online. Figures S1–S6 NMR, IR and high-resolution mass spectra of compound 6.

Author Contributions

Supervision and manuscript concept, A.A.D.; synthesis, O.B.Z.; synthesis, N.V.D.; synthesis, N.A.N.; single-crystal X-ray diffraction, K.Y.S.; synthesis, S.V.T.; supervision and manuscript concept, V.I.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Russian Foundation for Basic Research (RFBR) (Project “Stability” No 20-33-70011).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The NMR spectroscopy and X-ray diffraction data were obtained using equipment from the Center for Molecular Structure Studies at A.N. Nesmeyanov Institute of Organoelement Compounds, operating with support from the Ministry of Science and Higher Education of the Russian Federation.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of compound 6 are available from the authors.

References

  1. Hosmane, N.S.; Eagling, R. Handbook of Boron Science: With Applications in Organometallics, Catalysis, Materials and Medicine; World Scientific: London, UK, 2019; ISBN 978-981-4338-67-7. [Google Scholar]
  2. Cui, P.F.; Liu, X.R.; Guo, S.T.; Lin, Y.J.; Jin, G.X. Steric effects-directed B–H bond activation of para-carboranes. J. Am. Chem. Soc. 2021, 143, 5099–5105. [Google Scholar] [CrossRef]
  3. Cui, P.F.; Lin, Y.J.; Li, Z.H.; Jin, G.X. Dihydrogen bond interaction induced separation of hexane isomers by self-assembled carborane metallacycles. J. Am. Chem. Soc. 2020, 142, 8532–8538. [Google Scholar] [CrossRef] [PubMed]
  4. Hosmane, N.S.; Maguire, J.A. Comprehensive Organometallic Chemistry III; Michael, D., Mingos, P., Crabtree, R.H., Eds.; Elsevier: Amsterdam, The Netherlands, 2007; p. 264. ISBN 978-0-0804-4601-1. [Google Scholar]
  5. Poater, J.; Solà, M.; Viñas, C.; Teixidor, F. π-Aromaticity and three-dimensional aromaticity: Two sides of the same coin? Angew. Chem. Int. Ed. 2014, 53, 12191–12195. [Google Scholar] [CrossRef] [PubMed]
  6. Núñez, R.; Teixidor, F.; Kivekäs, R.; Sillanpää, R.; Viñas, C. Influence of the solvent and R groups on the structure of (carboranyl)R2PI2 compounds in solution. Crystal structure of the first iodophosphonium salt incorporating the anion [7,8-nido-C2B9H10]−. Dalton Trans. 2008, 11, 1471–1480. [Google Scholar] [CrossRef]
  7. Kolel-Veetil, M.K.; Keller, T.M. Formation of elastomeric network polymers from ambient heterogeneous hydrosilations of carboranylenesiloxane and branched siloxane monomers. Polym. Sci. Part A 2006, 44, 147–155. [Google Scholar] [CrossRef]
  8. Řezačova, P.; Cigler, P.; Matejiček, P.; Lipšik, M.; Pokorna, J.; Grüner, B.; Konvalinka, J. Medicinal Application of Carboranes: Inhibition of HIV Protease. In Boron Science: New Technologies and Applications; Hosmane, N.S., Ed.; CRC Press: Boca Raton, FL, USA, 2012; p. 41. ISBN 9781439826621. [Google Scholar]
  9. Hosmane, N.S.; Eagling, R. Handbook of Boron Chemistry in Organometallics Catalysis, Materials and Medicine; World Science Publishers: Hackensack, NJ, USA, 2018. [Google Scholar] [CrossRef]
  10. Kaszynski, P. closo-Boranes as Structural Elements for Liquid Crystals. In Boron Science: New Technologies and Applications; Hosmane, N.S., Ed.; CRC Press: Boca Raton, FL, USA, 2012; p. 319. ISBN 9781439826621. [Google Scholar]
  11. Sauerwein, W.A.G. Neutron Capture Therapy: Principles and Applications; Sauerwein, W.A.G., Wittig, A., Moss, R., Nakagawa, Y., Eds.; Springer: Berlin, Germany, 2012; p. 554. ISBN 978-3-642-31333-2. [Google Scholar]
  12. Bregadze, V.I.; Sivaev, I.B. Polyhedral Boron Compounds for BNCT. In Boron Science: New Technologies and Applications; Hosmane, N.S., Ed.; CRC Press: Boca Raton, FL, USA, 2012; p. 181. ISBN 9781439826621. [Google Scholar]
  13. Sibrian-Vazquez, M.; Vicente, M.G.H. Boron Tumor Delivery for BNCT: Recent Developments and Perspectives. In Boron Science: New Technologies and Applications; Hosmane, N.S., Ed.; CRC Press: Boca Raton, FL, USA, 2012; p. 209. ISBN 9781439826621. [Google Scholar]
  14. Lesnikowski, Z.J. Boron units as pharmacophores-New applications and opportunities of boron cluster chemistry. Collect. Czechoslov. Chem. Commun. 2007, 72, 1646–1658. [Google Scholar] [CrossRef]
  15. Sivaev, I.B.; Bregadze, V.I. Polyhedral boranes for medical applications: Current status and perspectives. Eur. J. Inorg. Chem. 2009, 11, 1433–1450. [Google Scholar] [CrossRef]
  16. Tsygankova, A.R.; Kanygin, V.V.; Kasatova, A.I.; Zavyalov, E.L.; Guselnikova, T.Y.; Kichigin, A.I.; Mukhamadiyarov, R.A. Determination of boron by inductively coupled plasma atomic emission spectroscopy. Biodistribution of 10B in tumor-bearing mice. Russ. Chem. Bull. Int. Ed. 2020, 69, 601–607. [Google Scholar] [CrossRef]
  17. Sivaev, I.B.; Bregadze, V.I. Boron neutron capture therapy. Chemical aspect. Ross. Khim. Zh. 2004, 48, 109. [Google Scholar]
  18. Valliant, J.F.; Guenther, K.J.; King, A.S.; Morel, P.; Schaffer, P.; Sogbein, O.O.; Stephenson, K.A. Coord. Chem. Rev. 2002, 232, 173–230. [Google Scholar] [CrossRef]
  19. Sivaev, I.B.; Bregadze, V.I.; Kuznetsov, N.T. Derivatives of the closo-dodecaborate anion and their application in medicine. Russ. Chem. Bull. 2002, 51, 1362–1374. [Google Scholar] [CrossRef]
  20. Cabrera-Gonzalez, J.; Xochitiotzi-Florez, E.; Vinas, C.; Teixidor, F.; Garcia, H.; Garcí a-Ortega, H.; Farfan, N.; Santillan, R.; Parella, T.; Nunez, R. High-boron-content porphyrin-cored aryl ether dendrimers: Controlled synthesis, characterization, and photophysical properties. Inorg. Chem. 2015, 54, 5021–5031. [Google Scholar] [CrossRef] [PubMed]
  21. Olusanya, T.; Haj Ahmad, R.; Ibegbu, D.; Smith, J.; Elkordy, A. Liposomal drug delivery systems and anticancer drugs. Molecules 2018, 23, 907–924. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Kuang, N.H.; Chupin, V.V.; Prokhorov, D.I.; Zhdanova, K.A.; Shvets, V.I. Liposomal delivery systems of biologically active compounds in the treatment of certain diseases. J. Fine Chem. Technol. 2014, 9, 26–41. (In Russian) [Google Scholar]
  23. Heber, E.M.; Hawthorne, M.F.; Kueffer, P.J.; Garabalino, M.A.; Thorp, S.I.; Pozzi, E.C.; Hughes, A.M.; Maitz, C.A.; Jalisatgi, S.S.; Nigg, D.W.; et al. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model. Proc. Natl. Acad. Sci. USA 2014, 111, 16077–16081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Maitz, C.A.; Khan, A.A.; Kueffer, P.J.; Brockman, J.D.; Dixson, J.; Jalisatgi, S.S.; Nigg, D.W.; Everett, T.A.; Hawthorne, M.F. Validation and comparison of the therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes in multiple murine tumor models. Transl. Oncol. 2017, 10, 686–692. [Google Scholar] [CrossRef]
  25. Bialek-Pietras, M.; Olejniczak, A.B.; Tachikawa, S.; Nakamura, H.; Lesnikowski, Z.J. Towards new boron carriers for boron neutron capture therapy: Metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates. Bioorg. Med. Chem. 2013, 21, 1136. [Google Scholar] [CrossRef] [PubMed]
  26. Bregadze, V.I.; Sivaev, I.B.; Dubey, R.D.; Semioshkin, A.; Shmal’ko, A.V.; Kosenko, I.D.; Lebedeva, K.V.; Mandal, S.; Sreejyothi, P.; Sarkar, A.; et al. Boron-containing lipids and liposomes: New conjugates of cholesterol with polyhedral boron hydrides. Chem. Eur. J. 2020, 26, 13832–13841. [Google Scholar] [CrossRef]
  27. Dubey, R.D.; Sarkar, A.; Shen, Z.; Bregadze, V.I.; Sivaev, I.B.; Druzina, A.A.; Zhidkova, O.B.; Shmal’ko, A.V.; Kosenko, I.D.; Sreejyothi, P.; et al. Effects of linkers on the development of liposomal formulation of cholesterol conjugated cobalt bis(dicarbollides). J. Pharm. Sci. 2020, 110, 1365–1373. [Google Scholar] [CrossRef]
  28. Lee, W.; Sarkar, S.; Ahn, H.; Kim, J.Y.; Lee, Y.J.; Chang, Y.; Yoo, J. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT). Biochem. Biophys. Res. Commun. 2020, 522, 669–675. [Google Scholar] [CrossRef]
  29. Giovenzana, G.B.; Lay, L.; Monti, D.; Palmisano, G.; Panza, L. Synthesis of carboranyl derivatives of alkynyl glycosides as potential BNCT agents. Tetrahedron 1999, 55, 14123–14136. [Google Scholar] [CrossRef]
  30. Ristori, S.; Salvati, A.; Martini, G.; Spalla, O.; Pietrangeli, D.; Posa, A.; Ricciardi, G. Synthesis and liposome insertion of a new poly(carboranylalkylthio)porphyrazine to improve potentiality in multiple-approach cancer therapy. J. Am. Chem. Soc. 2007, 129, 2728–2729. [Google Scholar] [CrossRef] [PubMed]
  31. Altieri, S.; Balzi, M.; Bortolussi, S.; Bruschi, P.; Ciani, L.; Clerici, A.M.; Faraoni, P.; Ferrari, C.; Gadan, M.A.; Panza, L.; et al. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy. J. Med. Chem. 2009, 52, 7829–7835. [Google Scholar] [CrossRef]
  32. Druzina, A.A.; Kosenko, I.D.; Zhidkova, O.B.; Ananyev, I.V.; Timofeev, S.V.; Bregadze, V.I. Novel cobalt bis(dicarbollide) based on terminal alkynes and their “click” reactions. Eur. J. Inorg. Chem. 2020, 27, 2658–2665. [Google Scholar] [CrossRef]
  33. Druzina, A.A.; Zhidkova, O.B.; Dudarova, N.V.; Kosenko, I.D.; Ananyev, I.V.; Timofeev, S.V.; Bregadze, V.I. Synthesis and structure of nido-carboranyl azide and its “click” reactions. Molecules 2021, 26, 530–544. [Google Scholar] [CrossRef]
  34. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective ligation of azides and terminal alkynes. Angew. Chem. Int. Ed. 2002, 41, 2596–2599. [Google Scholar] [CrossRef]
  35. Tornøe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057–3064. [Google Scholar] [CrossRef] [PubMed]
  36. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. [Google Scholar] [CrossRef]
  37. Wojtczak, B.A.; Andrysiak, A.; Grüner, B.; Lesnikowski, Z.J. “Chemical ligation”: A versatile method for nucleoside modification with boron clusters. Chem. Eur. J. 2008, 14, 10675–10682. [Google Scholar] [CrossRef]
  38. Bregadze, V.I.; Semioshkin, A.A.; Las´kova, J.N.; Berzina, M.Y.; Lobanova, I.A.; Sivaev, I.B.; Grin, M.A.; Titeev, R.A.; Brittal, D.I.; Ulybina, O.V.; et al. Novel types of boronated chlorine e6 conjugates via «click chemistry». Appl. Organometal. Chem. 2009, 23, 370–374. [Google Scholar] [CrossRef]
  39. Druzina, A.A.; Shmalko, A.V.; Andreichuk, E.P.; Zhidkova, O.B.; Kosenko, I.D.; Semioshkin, A.A.; Sivaev, I.B.; Mandal, S.; Shen, Z.; Bregadze, V.I. “Click” synthesis of cobalt bis(dicarbollide)-cholesterol conjugates. Mendeleev Commun. 2019, 29, 628–630. [Google Scholar] [CrossRef]
  40. Druzina, A.A.; Zhidkova, O.B.; Kosenko, I.D. Synthesis of conjugates of closo-dodecaborate dianion with cholesterol using a “click” reaction. Russ. Chem. Bull. Int. Ed. 2020, 69, 1080–1084. [Google Scholar] [CrossRef]
  41. Druzina, A.A.; Stogniy, M.Y. Synthesis of cholesterol derivatives based on closo- and nido-carboranes. Chem. Bull. Int. Ed. 2021, 70, 527–532. [Google Scholar] [CrossRef]
  42. Timofeev, S.V.; Zhidkova, O.B.; Prikaznova, E.A.; Sivaev, I.B.; Semioshkin, A.; Godovikov, I.A.; Starikova, Z.A.; Bregadze, V.I. Direct synthesis of nido-carborane derivatives with pendant functional groups by copper-promoted reactions with dimethylalkylamines. J. Organomet. Chem. 2014, 757, 21. [Google Scholar] [CrossRef]
  43. Medvedev, M.G.; Bushmarinov, I.S.; Sun, J.W.; Perdew, J.P.; Lyssenko, K.A. Density functional theory is straying from the path toward the exact functional. Science 2017, 355, 49–52. [Google Scholar] [CrossRef]
  44. Suponitsky, K.Y.; Anisimov, A.A.; Anufriev, S.A.; Sivaev, I.B.; Bregadze, V.I. 1,12-Diiodo-ortho-carborane: A classic textbook example of the dihalogen bond. Crystals 2021, 11, 396. [Google Scholar] [CrossRef]
  45. Suponitsky, K.Y.; Masunov, A.E.; Antipin, M.Y. Computational search for nonlinear optical materials: Are polarization functions important in the hyperpolarizability predictions of molecules and aggregates? Mendeleev Commun. 2009, 19, 311–313. [Google Scholar] [CrossRef]
  46. Suponitsky, K.Y.; Tafur, S.; Masunov, A.E. Applicability of hybrid density functional theory methods to calculation of molecular hyperpolarizability. J. Chem. Phys. 2008, 129, 044109. [Google Scholar] [CrossRef]
  47. Zhang, X.; Yang, X.; Zhang, S. Synthesis of triazole-linked glycoconjugates by copper(I)-catalyzed regiospecific cycloaddition of alkynes and azides. Synth. Commun. 2009, 39, 830–844. [Google Scholar] [CrossRef]
  48. APEX2 and SAINT; Bruker AXS Inc.: Madison, WI, USA, 2014.
  49. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Cryst. C 2015, 71, 3–8. [Google Scholar] [CrossRef]
Molecules 26 06687 g001 550
Figure 1. Molecular view of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4 presented by thermal ellipsoids at 50% probability level. Shortened H4A…H12 and H4…H1A contacts are shown by dashed lines.
Figure 1. Molecular view of 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4 presented by thermal ellipsoids at 50% probability level. Shortened H4A…H12 and H4…H1A contacts are shown by dashed lines.
Molecules 26 06687 g001
Molecules 26 06687 sch001 550
Scheme 1. Synthesis of zwitter-ionic nido-carboranyl conjugate with cholesterol 6.
Scheme 1. Synthesis of zwitter-ionic nido-carboranyl conjugate with cholesterol 6.
Molecules 26 06687 sch001
Molecules 26 06687 g002 550
Figure 2. Molecular view of 9-NC≡CCH2Me2N-nido-7,8-C2B9H11 (a) and 9-PhCH2Me2N-nido-7,8-C2B9H11 (b). Only necessary numbering is provided. Shortened H4…H1A contacts are shown by dashed lines.
Figure 2. Molecular view of 9-NC≡CCH2Me2N-nido-7,8-C2B9H11 (a) and 9-PhCH2Me2N-nido-7,8-C2B9H11 (b). Only necessary numbering is provided. Shortened H4…H1A contacts are shown by dashed lines.
Molecules 26 06687 g002
Table
Table 1. Torsion angles (degree) and shortened H…H contacts (Å) defining the orientation of side substituents relative to the carborane cage for the compounds 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4, 9-NC≡CCH2Me2N-nido-7,8-C2B9H11 and 9-PhCH2Me2N-nido-7,8-C2B9H11.
Table 1. Torsion angles (degree) and shortened H…H contacts (Å) defining the orientation of side substituents relative to the carborane cage for the compounds 9-Me2N(CH2)2Me2N-nido-7,8-C2B9H11 4, 9-NC≡CCH2Me2N-nido-7,8-C2B9H11 and 9-PhCH2Me2N-nido-7,8-C2B9H11.
Torsion Angle or H…H Contact9-Me2N(CH2)2Me2N-Nido-7,8-C2B9H11 49-NC≡CCH2Me2N-Nido-7,8-C2B9H119-PhCH2Me2N-Nido-7,8-C2B9H11
X-rayDFTX-rayDFTX-rayDFT
C8-B9-N1-C119.4(2)28.350.4(2)36.035.3(2)41.9
C8-B9-N1-C2138.4(2)148.0172.4(2)157.8155.8(2)162.2
C8-B9-N1-C3−103.6(2)−94.7−69.2(2)−84.1−84.8(2)−78.8
B9-N1-C3-C464.0(2)63.9177.4(2)179.6171.9(2)−179.7
N1-C3-C4-N2178.3(2)−170.6––––
C3-C4-N2-C574.1(2)81.5––––
C3-C4-N2-C6−163.1(2)−152.8––––
H4…H1A2.332.292.262.242.332.27
H4A…H122.382.39––––
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Druzina, A.A.; Zhidkova, O.B.; Dudarova, N.V.; Nekrasova, N.A.; Suponitsky, K.Y.; Timofeev, S.V.; Bregadze, V.I. Synthesis of Zwitter-Ionic Conjugate of Nido-Carborane with Cholesterol. Molecules 2021, 26, 6687. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26216687

AMA Style

Druzina AA, Zhidkova OB, Dudarova NV, Nekrasova NA, Suponitsky KY, Timofeev SV, Bregadze VI. Synthesis of Zwitter-Ionic Conjugate of Nido-Carborane with Cholesterol. Molecules. 2021; 26(21):6687. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26216687

Chicago/Turabian Style

Druzina, Anna A., Olga B. Zhidkova, Nadezhda V. Dudarova, Natalia A. Nekrasova, Kyrill Yu. Suponitsky, Sergey V. Timofeev, and Vladimir I. Bregadze. 2021. "Synthesis of Zwitter-Ionic Conjugate of Nido-Carborane with Cholesterol" Molecules 26, no. 21: 6687. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26216687

Article Metrics

Back to TopTop